Literature DB >> 26669755

Synthesis and structure-activity relationships of novel lincomycin derivatives. Part 1. Newly generated antibacterial activities against Gram-positive bacteria with erm gene by C-7 modification.

Yoshinari Wakiyama1, Ko Kumura1, Eijiro Umemura1, Kazutaka Ueda1, Satomi Masaki1, Megumi Kumura1, Hideki Fushimi1, Keiichi Ajito1.   

Abstract

We synthesized 7(S)-7-deoxy-7-arylthiolincomycin derivatives possessing a heterocyclic ring at the C-7 position via sulfur atom by either Mitsunobu reaction of 2,3,4-tris-O-(trimethylsiliyl)lincomycin or SN2 reaction of 7-O-methanesulfonyl-2,3,4-tri-O-trimethylsiliyllincomycin. As a result, 7(S)-7-deoxy-7-arylthiolincomycin derivatives 16, 21 and 27 exhibited antibacterial activities against respiratory infection-related Gram-positive bacteria with erm gene, although clindamycin did not have any activities against those pathogens. Furthermore, 7(S)-configuration of lincomycin derivatives was found to be necessary for enhancing antibacterial activities from the comparison results of configurations of 16 (S-configuration) and 30 (R-configuration) at the 7-position.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26669755     DOI: 10.1038/ja.2015.119

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  28 in total

Review 1.  Macrolide resistance conferred by base substitutions in 23S rRNA.

Authors:  B Vester; S Douthwaite
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  The FDA and the case of Ketek.

Authors:  David B Ross
Journal:  N Engl J Med       Date:  2007-04-19       Impact factor: 91.245

3.  Molecular characterization of the first telithromycin-resistant Streptococcus pneumoniae isolate in Germany.

Authors:  Ralf René Reinert; Mark van der Linden; Adnan Al-Lahham
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

4.  Lincomycin. XI. Synthesis and structure of clindamycin. A potent antibacterial agent.

Authors:  R D Birkenmeyer; F Kagan
Journal:  J Med Chem       Date:  1970-07       Impact factor: 7.446

5.  Modifications of lincomycin involving the carbohydrate portion. I. The 2-O-methyl and 2-deoxy-analogues.

Authors:  B Bannister
Journal:  J Chem Soc Perkin 1       Date:  1972

6.  Chemical modification of lincomycin.

Authors:  B J Magerlein; R D Birkenmeyer; F Kagan
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1966

7.  Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance.

Authors:  Daqi Tu; Gregor Blaha; Peter B Moore; Thomas A Steitz
Journal:  Cell       Date:  2005-04-22       Impact factor: 41.582

8.  A ketolide resistance mutation in domain II of 23S rRNA reveals the proximity of hairpin 35 to the peptidyl transferase centre.

Authors:  L Xiong; S Shah; P Mauvais; A S Mankin
Journal:  Mol Microbiol       Date:  1999-01       Impact factor: 3.501

9.  Lincomycin. X. The chemical synthesis of lincomycin.

Authors:  B J Magerlein
Journal:  Tetrahedron Lett       Date:  1970-01       Impact factor: 2.415

10.  Telithromycin: the perils of hasty adoption and persistence of off-label prescribing.

Authors:  Patrick P Gleason; Carol Walters; Alan H Heaton; Jeremy A Schafer
Journal:  J Manag Care Pharm       Date:  2007-06
View more
  6 in total

1.  Synthesis and structure-activity relationships of novel lincomycin derivatives. Part 2. Synthesis of 7(S)-7-deoxy-7-(4-morpholinocarbonylphenylthio)lincomycin and its 3-dimensional analysis with rRNA.

Authors:  Yoshinari Wakiyama; Ko Kumura; Eijiro Umemura; Satomi Masaki; Kazutaka Ueda; Takashi Watanabe; Mikio Yamamoto; Yoko Hirai; Keiichi Ajito
Journal:  J Antibiot (Tokyo)       Date:  2015-12-16       Impact factor: 2.649

2.  Synthesis and SARs of novel lincomycin derivatives Part 5: optimization of lincomycin analogs exhibiting potent antibacterial activities by chemical modification at the 6- and 7-positions.

Authors:  Yoshinari Wakiyama; Ko Kumura; Eijiro Umemura; Satomi Masaki; Kazutaka Ueda; Yasuo Sato; Yoko Hirai; Yoshio Hayashi; Keiichi Ajito
Journal:  J Antibiot (Tokyo)       Date:  2017-11-01       Impact factor: 2.649

3.  Synthesis and structure-activity relationships of novel lincomycin derivatives part 3: discovery of the 4-(pyrimidin-5-yl)phenyl group in synthesis of 7(S)-thiolincomycin analogs.

Authors:  Yoshinari Wakiyama; Ko Kumura; Eijiro Umemura; Satomi Masaki; Kazutaka Ueda; Yasuo Sato; Takashi Watanabe; Yoko Hirai; Keiichi Ajito
Journal:  J Antibiot (Tokyo)       Date:  2016-10-05       Impact factor: 2.649

4.  Synthesis and structure-activity relationships of novel lincomycin derivatives. Part 4: synthesis of novel lincomycin analogs modified at the 6- and 7-positions and their potent antibacterial activities.

Authors:  Yoshinari Wakiyama; Ko Kumura; Eijiro Umemura; Kazutaka Ueda; Takashi Watanabe; Keiko Yamada; Takafumi Okutomi; Keiichi Ajito
Journal:  J Antibiot (Tokyo)       Date:  2017-05-31       Impact factor: 2.649

5.  Synthesis and antibacterial activity of novel lincomycin derivatives. IV. Optimization of an N-6 substituent.

Authors:  Ko Kumura; Yoshinari Wakiyama; Kazutaka Ueda; Eijiro Umemura; Yoko Hirai; Keiko Yamada; Keiichi Ajito
Journal:  J Antibiot (Tokyo)       Date:  2017-11-08       Impact factor: 2.649

6.  Synthesis and antibacterial activity of novel lincomycin derivatives. III. Optimization of a phenyl thiadiazole moiety.

Authors:  Ko Kumura; Yoshinari Wakiyama; Kazutaka Ueda; Eijiro Umemura; Takashi Watanabe; Mikio Yamamoto; Takuji Yoshida; Keiichi Ajito
Journal:  J Antibiot (Tokyo)       Date:  2017-07-05       Impact factor: 2.649

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.